微针治疗瘢痕:120例前瞻性长期随访研究
该前瞻性观察研究纳入120例面部与非面部瘢痕患者(皮肤光型I至VI型),采用机械微针装置治疗,不使用其他局部或病灶内辅助治疗。盲法评估显示所有瘢痕平均经2.5次治疗后改善至少50%,超过80%患者改善50%至75%,65%患者改善超过75%;面部与非面部、萎缩性痤疮瘢痕与创伤或手术瘢痕间疗效无显著临床差异,不良反应风险小。
要点
- 微针可使多种面部与非面部瘢痕平均2.5次治疗后改善至少50%
- 超过80%患者改善50%至75%,65%患者改善超过75%
- 面部与非面部、痤疮与创伤/手术瘢痕疗效无显著临床差异
核心结论
- 微针可用于多种面部与非面部瘢痕及广泛皮肤光型,不良反应风险小。
- 需进一步研究建立标准化方案以优化不同瘢痕类型的疗效。
研究设计与样本
- 前瞻性观察研究,纳入120例连续患者,皮肤光型I至VI型。
- 瘢痕源于痤疮、创伤、手术,分布于面部与非面部。
- 采用机械微针装置治疗,不施加其他局部或病灶内辅助治疗。
- 两名对治疗方案盲法的评估者在治疗后1、3、6、12个月以五点量表评定改善。
主要发现
- 患者接受1至6次连续每月微针治疗。
- 所有瘢痕平均经2.5次治疗后改善至少50%。
- 超过80%患者改善50%至75%,65%患者改善超过75%。
- 面部与非面部瘢痕、萎缩性痤疮瘢痕与创伤或手术瘢痕的疗效无显著临床差异。
关键数值与推荐
- 改善程度采用五点量表由两名盲法评估者在1、3、6、12个月评定。
- 所有瘢痕改善至少50%,平均治疗2.5次。
- 超过80%患者改善50%至75%,65%患者改善超过75%。
- 证据等级:治疗性研究,IV级。
临床怎么用
- 微针可作为面部与非面部多种瘢痕的微创治疗选择,不良反应风险小。
- 治疗次数可为1至6次每月治疗,本研究中平均2.5次即见至少50%改善。
局限性
- 为前瞻性观察研究,证据等级IV级。
- 既往研究样本小、设备与方案及随访差异大,标准化方案尚待建立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In recent years, microneedling has been increasingly used to treat a number of dermatologic conditions, including scars. Although initial studies demonstrated improvement of (mostly) atrophic scars with microneedling, the number of patients evaluated was relatively small, and the devices and treatment protocols used and posttreatment follow-up varied widely. Through this prospective observational study, the results of microneedling on 120 patients with a variety of scars are described. METHODS: One hundred twenty consecutive patients (skin phototypes I through VI) with facial and nonfacial scars from a variety of etiologic sources (acne, trauma, surgery) were treated using a mechanical microneedling device. No additional treatments (topical or intralesional) were applied. Two assessors blinded to treatment protocol rated clinical improvement of scars 1, 3, 6, and 12 months after treatment on a five-point scale. Side effects were monitored and tabulated. RESULTS: Patients received one to six consecutive monthly microneedling treatments. All scars improved at least 50 percent after an average of 2.5 treatments. Over 80 percent of patients had 50 to 75 percent improvement, and 65 percent of patients demonstrated over 75 percent improvement. No significant clinical differences were observed in treatment responses of facial scars versus nonfacial scars nor between responses of atrophic acne scars and traumatic or surgical scars. CONCLUSIONS: This study supports the use of microneedling for various facial and nonfacial scars across a broad range of skin phototypes with minimal risk of adverse effects. Further studies will help to establish standardized protocols to optimize treatment outcomes for different scar types. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Alster TS, Li MKY. Microneedling of Scars: A Large Prospective Study with Long-Term Follow-Up. Plast Reconstr Surg. 2020. PMID: 31985622. doi:10.1097/PRS.0000000000006462
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。